Vasectomy Market Research Report- Forecast till 2027

Vasectomy Market Information: By Type (Conventional Vasectomy, No-Scalpel Vasectomy, Minimally Invasive Vasectomy), Drug (Anesthetics, Painkillers, Antibiotics), Patient (Humans, Animals), End User (Hospitals And Clinics) - Forecast Till 2027

ID: MRFR/MED/3282-HCR | | Region: Global | 110 pages

Vasectomy Market Overview


Vasectomy is permanent male sterilization surgery, which involves the male vas deferens being severed to prevent sperm from entering into the urethra and thus preventing fertilization. Vasectomy is performed by several methods such as open or conventional vasectomy, no-scalpel techniques or minimally invasive technique. Vasectomy is a permanent procedure as a reversal is costly and often does not restore the male's fertility due to low sperm count or sperm motility. Vasectomy is a simple surgical procedure, which takes less than thirty minutes and no hospital stay.  Most vasectomy patients can resume their sexual behavior within a week with little or no discomfort. Vasectomy may in some cases cause sperm granulomas due to the entry of the sperm into the scrotum and vasitis nodosa, which is a benign proliferation of the ductular epithelium. Vasectomy in about 60%-70% of cases causes anti-sperm antibodies.


Vasectomy is the most effective permanent contraception for men and has more positive outlook such as more cost-effective, less invasive, and has a much lower risk of postoperative complications. Almost 90% of men had reported satisfaction with vasectomy especially when both people in the relationship agreed on the procedure. Despite medical advances and the demonstration of the superiority of vasectomy, female sterilization is the most widely used method worldwide, with approx. 250 million tubectomy surgeries compared to a pitiful of approximately 30 million vasectomies. The vasectomy market is expected to reach USD 24.0 billion at a CAGR of ~ 7.1 % during the by the end of forecast period 2017-2023. The market drivers for vasectomy market are rising demand due to growing population, increasing male-female equality, side effects of female contraception such as risk of cancer, hormonal disturbances, osteoporosis, rise in body weight etc., high safety profile of vasectomy and its simplicity over tubectomy, low cost of the surgical procedure and lack of hospitalization and others. The market restraints are the complications such as the risk of bleeding, infections, etc., lack of awareness, issues of male supremacy coupled with the non-reversible nature of vasectomy, social taboo, especially, in the developing regions and others.


Key Players in the Vasectomy Market


Some of the key players profiled in the vasectomy market report are Pfizer, Inc., Abbott, GlaxoSmithKline plc, Sanofi S.A., Novartis AG, Bayer AG, Bristol Myers Squibb Company, Eli Lilly and Company, Inc., Accurate Surgical & Scientific Instruments Corporation, Sklar Surgical Instruments, Advanced Meditech International and others.


Intended Audience



  • Global Vasectomy manufacturers & suppliers

  • Research and development (R&D) companies

  • Hospitals and clinics

  • Academic institutes and universities


Figure 1          Global Vasectomy Market by Type, 2016 (%) Global Vasectomy Market

Segments


The vasectomy market has been classified  into type, drugs,  end user, and patients,


On the basis of type, the vasectomy market has been segmented as conventional vasectomy, no-scalpel vasectomy, and minimally invasive vasectomy.


Based on the drugs, the vasectomy market has been segmented as anesthetics, painkillers, antibiotics, and others.


Based on the patients, the vasectomy market has been segmented as human and animals.


Based on the end user, the vasectomy market has been segmented as hospitals and clinics, research and academics, and others.


Research Methodology
Vasectomy Market
Sources: Mayo Clinic, Healthline Media, MRFR Analysis


Regional Analysis


The Americas account for a major share of the market owing to high expenditure on the health care, especially, of the U.S. and Canada. Additionally, the greater number of vasectomies due to greater male-female equality in the U.S. and Canada drives the vasectomy market. The high concentration of the major hospitals in the developed countries of this region coupled with good reimbursement rates is adding fuel to the market growth. Moreover, the large share of surgeries in the returns of hospitals favors the market. Canada has a higher rate of people undergoing vasectomies than the U.S.


Europe is the second largest market in the world due to growing the pharmaceutical and industrial base. The European market growth is led by countries such as Germany and France. Germany is expected to be the fastest growing market over the assessment period. Belgium, Denmark, and Switzerland have a higher rate of people undergoing vasectomies than other nations of Europe.


Asia Pacific region is expected to proliferate; China and India are likely to lead this market due to the fast-growing healthcare sector and large unmet needs over the forecast period. India was the first nation in the world to include population control as a national program way back in 1952. South East Asian countries such as China, India, and Malaysia are projected to contribute highly to the market growth. The growing penetration of healthcare industry in the Asia Pacific region is expected to drive the future vasectomy market in the region.


Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market. Other Middle East nations to watch out for are Kuwait, Jordan, Egypt, and Iran. The African region is expected to witness a poor growth owing to weak economic and political conditions, and inadequate healthcare development. Botswana and South Africa are expected to be the future markets with approximately 1% rate of people undergoing vasectomies. Other regions are projected to be laggards due to the poor social development and tribal identities such as sub-Saharan Africa.



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   7.1 % (2017-2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Drugs, End user, and Patients
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Pfizer, Inc., Abbott, GlaxoSmithKline plc, Sanofi S.A., Novartis AG, Bayer AG, Bristol Myers Squibb Company, Eli Lilly and Company, Inc., Accurate Surgical & Scientific Instruments Corporation, Sklar Surgical Instruments, Advanced Meditech International and others
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Rising demand due to growing population
  • Increasing male-female equality
  • Side effects of female contraception


  • Speak to Analyst Ask for Customization

    Table Of Content

    1. Report Prologue

    2. Market Introduction

    2.1 Definition

    2.2 Scope Of The Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary Research

    3.4 Market Size Estimation

    4. Market Dynamics

    4.1 Drivers

    4.2 Restrains

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Technology Trends & Assessment

    5. Market Factor Analysis

    5.1 Porters Five Forces Analysis

    5.2 Value Chain Analysis

    5.3 Investment Feasibility Analysis

    5.4 Pricing Analysis

    6. Global Vasectomy Market, By Type

    6.1 Introduction

    6.2 Conventional Vasectomy

    6.2.1 Market Estimates & Forecast, 2020-2027

    6.3 No-Scalpel Vasectomy

    6.3.1 Market Estimates & Forecast, 2020-2027

    6.4 Minimally Invasive Vasectomy

    6.4.1 Market Estimates & Forecast, 2020-2027

    7. Global Vasectomy Market, By Drugs

    7.1 Introduction

    7.2 Anesthetics

    7.2.1 Market Estimates & Forecast, 2020-2027

    7.3 Pain Killers

    7.3.1 Market Estimates & Forecast, 2020-2027

    7.4 Antibiotics

    7.4.1 Market Estimates & Forecast, 2020-2027

    7.5 Others

    7.5.1 Market Estimates & Forecast, 2020-2027

    8. Global Vasectomy Market, By Patients

    8.1 Introduction

    8.2 Humans

    8.2.1 Market Estimates & Forecast, 2020-2027

    8.3 Animals

    8.3.1 Market Estimates & Forecast, 2020-2027

    9. Global Vasectomy Market, By End-User

    9.1 Introduction

    9.2 Hospitals And Clinics

    9.2.1 Market Estimates & Forecast, 2020-2027

    9.3 Research And Academics

    9.3.1 Market Estimates & Forecast, 2020-2027

    9.4 Others

    9.4.1 Market Estimates & Forecast, 2020-2027

    10. Global Vasectomy Market, By Region

    10.1 Introduction

    10.2 Americas

    10.2.1 North America

    10.2.1.1 U.S.

    10.2.1.2 Canada

    10.2.2 South America

    10.3 Europe

    10.3.1 Western Europe

    10.3.1.1 Germany

    10.3.1.2 France

    10.3.1.3 U.K

    10.3.1.4 Italy

    10.3.1.5 Spain

    10.3.1.6 Rest Of Western Europe

    10.3.2 Eastern Europe

    10.4 Asia Pacific

    10.4.1 Japan

    10.4.2 China

    10.4.3 India

    10.4.4 Australia

    10.4.5 Republic Of Korea

    10.4.6 Rest Of Asia Pacific

    10.5 The Middle East & Africa

    10.5.1 United Arab Emirates

    10.5.2 Saudi Arabia

    10.5.3 Oman

    10.5.4 Kuwait

    10.5.5 Qatar

    10.5.6 Rest Of The Middle East & Africa

    11 Company Landscape

    11.1 Introduction

    11.2 Market Share Analysis

    11.3 Key Development & Strategies

    11.3.1 Key Developments

    12 Company Profiles

    12.1 Pfizer, Inc.

    12.1.1 Overview

    12.1.2 Product Overview

    12.1.3 Financials

    12.1.4 Key GlaxoSmithKline Plc

    12.2.1 Overview

    12.2.2 Product Overview

    12.2.3 Financials

    12.2.4 Key Developments

    12.3 Sanofi S.A.

    12.3.1 Overview

    12.3.2 Product Overview

    12.3.3 Financials

    12.3.4 Key Development

    12.4 Accurate Surgical & Scientific Instruments Corporation

    12.4.1 Overview

    12.4.2 Product Overview

    12.4.3 Financials

    12.4.4 Key Development

    12.5 Sklar Surgical Instruments

    12.5.1 Overview

    12.5.2 Product Overview

    12.5.3 Financials

    12.5.4 Key Development

    12.6 Novartis AG

    12.6.1 Overview

    12.6.2 Product Overview

    12.6.3 Financials

    12.6.4 Key Development

    12.7 Abbott

    12.7.1 Overview

    12.7.2 Product Overview

    12.7.3 Financials

    12.7.4 Key Development

    12.8 Advanced Meditech International

    12.8.1 Overview

    12.8.2 Product Overview

    12.8.3 Financials

    12.8.4 Key Development

    12.9 Others

    13 MRFR Conclusion

    13.1 Key Findings

    13.1.1 From CEO’s View Point

    13.1.2 Unmet Needs Of The Market

    13.2 Key Companies To Watch

    13.3 Prediction Of Vasectomy Industry

    14 Appendix

    List Of Tables

    TABLE 1 GLOBAL VASECTOMY MARKET, BY TYPE, 2020-2027 (USD MILLION)

    TABLE 2 ASEPTIC ISOLATORS FOR VASECTOMY MARKET, BY REGION, 2020-2027 (USD MILLION)

    TABLE 3 CONVENTIONAL VASECTOMY FOR VASECTOMY MARKET, BY REGION 2020-2027 (USD

    MILLION)

    TABLE 4 NO-SCALPEL VASECTOMY FOR VASECTOMY MARKET, BY REGION 2020-2027 (USD MILLION)

    TABLE 5 MINIMALLY INVASIVE VASECTOMY FOR VASECTOMY MARKET, BY REGION 2020-2027 (USD MILLION)

    TABLE 6 GLOBAL VASECTOMY MARKET, BY DRUGS, 2020-2027 (USD MILLION)

    TABLE 7 ANESTHETICS FOR VASECTOMY MARKET, BY REGION, 2020-2027 (USD MILLION)

    TABLE 8 PAIN KILLERS FOR VASECTOMY MARKET, BY REGION 2020-2027 (USD MILLION)

    TABLE 9 ANTIBIOTICS FOR VASECTOMY MARKET, BY REGION 2020-2027 (USD MILLION)

    TABLE 10 OTHERS FOR VASECTOMY MARKET, BY REGION 2020-2027 (USD MILLION)

    TABLE 11 GLOBAL VASECTOMY MARKET, BY PATIENTS, 2020-2027 (USD MILLION)

    TABLE 12 HUMANS FOR VASECTOMY MARKET, BY REGION, 2020-2027 (USD MILLION)

    TABLE 13 ANIMALS FOR VASECTOMY MARKET, BY REGION 2020-2027 (USD MILLION)

    TABLE 14 GLOBAL VASECTOMY MARKET, BY END USER, 2020-2027 (USD MILLION)

    TABLE 15 NORTH AMERICA VASECTOMY MARKET, BY COUNTRY 2020-2027 (USD MILLION)

    TABLE 16 NORTH AMERICA VASECTOMY MARKET, BY TYPE 2020-2027 (USD MILLION)

    TABLE 17 NORTH AMERICA VASECTOMY MARKET, BY DRUGS 2020-2027 (USD MILLION)

    TABLE 18 NORTH AMERICA VASECTOMY MARKET, BY PATIENTS 2020-2027 (USD MILLION)

    TABLE 19 NORTH AMERICA VASECTOMY MARKET, BY END USER, 2020-2027 (USD MILLION)

    TABLE 20 NORTH AMERICA VASECTOMY MARKET BY REGION 2020-2027 (USD MILLION

    TABLE 21 EUROPE VASECTOMY MARKET, BY COUNTRY 2020-2027 (USD MILLION)

    TABLE 22 EUROPE VASECTOMY MARKET, BY TYPE 2020-2027 (USD MILLION)

    TABLE 23 EUROPE VASECTOMY MARKET, BY DRUGS 2020-2027 (USD MILLION)

    TABLE 24 EUROPE VASECTOMY MARKET, BY PATIENTS 2020-2027 (USD MILLION)

    TABLE 25 EUROPE VASECTOMY MARKET, BY END USER, 2020-2027 (USD MILLION)

    TABLE 26 EUROPE VASECTOMY MARKET BY REGION 2020-2027 (USD MILLION)

    TABLE 27 ASIA PACIFIC VASECTOMY MARKET, BY COUNTRY 2020-2027 (USD MILLION)

    TABLE 28 ASIA PACIFIC VASECTOMY MARKET, BY TYPE 2020-2027 (USD MILLION)

    TABLE 29 ASIA PACIFIC VASECTOMY MARKET, BY DRUGS 2020-2027 (USD MILLION)

    TABLE 30 ASIA PACIFIC VASECTOMY MARKET, BY PATIENTS 2020-2027 (USD MILLION)

    TABLE 31 ASIA PACIFIC VASECTOMY MARKET, BY END USER, 2020-2027 (USD MILLION)

    TABLE 32 ASIA PACIFIC VASECTOMY MARKET BY REGION 2020-2027 (USD MILLION

    TABLE 33 MIDDLE EAST & AFRICA VASECTOMY MARKET, BY COUNTRY 2020-2027 (USD MILLION)

    TABLE 34 MIDDLE EAST & AFRICA VASECTOMY MARKET, BY TYPE 2020-2027 (USD MILLION)

    TABLE 35 MIDDLE EAST & AFRICA VASECTOMY MARKET, BY DRUGS 2020-2027 (USD MILLION)

    TABLE 36 MIDDLE EAST & AFRICA VASECTOMY MARKET, BY PATIENTS 2020-2027 (USD MILLION)

    TABLE 37 MIDDLE EAST & AFRICA VASECTOMY MARKET, BY END USER, 2020-2027 (USD MILLION)

    TABLE 38 MIDDLE EAST & AFRICA VASECTOMY MARKET BY REGION 2020-2027 (USD MILLION

    List Of Figures

    FIGURE 1 RESEARCH PROCESS

    FIGURE 2 MARKET DYNAMICS FOR GLOBAL VASECTOMY MARKET

    FIGURE 3 GLOBAL VASECTOMY MAKRET, BY SEGMENT, 2020

    FIGURE 4 GLOBAL VASECTOMY SUCCESS MARKET, BY REGION

    FIGURE 5 GLOBAL VASECTOMY MARKET SHARE, BY TYPE 2020

    FIGURE 6 GLOBAL VASECTOMY MARKET SHARE, BY SYSTEM 2020

    FIGURE 7 GLOBAL VASECTOMY MARKET SHARE, BY PATIENTS 2020

    FIGURE 8 GLOBAL VASECTOMY MARKET SHARE, BY END USER, 2020

    FIGURE 9 GLOBAL VASECTOMY MARKET SHARE, 2020

    FIGURE 10 GLOBAL VASECTOMY MARKET SHARE, BY REGION, 2020

    FIGURE 11 NORTH AMERICA VASECTOMY MARKET SHARE, BY COUNTRY, 2020

    FIGURE 12 EUROPE VASECTOMY MARKET SHARE, BY COUNTRY, 2020

    FIGURE 13 ASIA PACIFIC VASECTOMY MARKET SHARE, BY COUNTRY, 2020

    FIGURE 14 MIDDLE EAST & AFRICA VASECTOMY MARKET, BY REGION, 2020

    FIGURE 15 GLOBAL VASECTOMY MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

    FIGURE 16 ACCURATE SURGICAL & SCIENTIFIC INSTRUMENTS CORPORATION.: KEY FINANCIALS

    FIGURE 17 ACCURATE SURGICAL & SCIENTIFIC INSTRUMENTS CORPORATION.: SEGMENTAL REVENUE

    FIGURE 18 ACCURATE SURGICAL & SCIENTIFIC INSTRUMENTS CORPORATION.: GEOGRAPHICAL REVENUE

    FIGURE 19 PFIZER, INC.: KEY FINANCIALS

    FIGURE 20 PFIZER, INC.: SEGMENTAL REVENUE

    FIGURE 21 PFIZER, INC.: GEOGRAPHICAL REVENUE

    FIGURE 22 ADVANCED MEDITECH INTERNATIONAL: KEY FINANCIALS

    FIGURE 23 ADVANCED MEDITECH INTERNATIONAL: SEGMENTAL REVENUE

    FIGURE 24 ADVANCED MEDITECH INTERNATIONAL: GEOGRAPHICAL REVENUE

    FIGURE 25 ABBOTT: KEY FINANCIALS

    FIGURE 26 ABBOTT: SEGMENTAL REVENUE

    FIGURE 27 ABBOTT: GEOGRAPHICAL REVENUE

    FIGURE 28 SKLAR SURGICAL INSTRUMENTS: FINANCIAL REVENUE

    FIGURE 29 SKLAR SURGICAL INSTRUMENTS: SEGMENTAL REVENUE

    FIGURE 30 SKLAR SURGICAL INSTRUMENTS: GEOGRPAHICAL REVENUE